Avelas Biosciences
4 known investors
Find your way into Avelas Biosciences
Sign up to see every warm intro you have to Avelas Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avelas Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Investors · 4
Torrey Pines Investmentlisted by Torrey Pines InvestmentSan Diego
How we know: Torrey Pines Investment's portfolio page · prnewswire.com · Not right? Tell us
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
Also in the syndicate · 2
WuXi AppTecWuXi PharmaTech Investments
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CAug 2016Source ↗
- Undisclosed amountSeries BSep 2014
Avalon Ventures, Torrey Pines Investment, WuXi PharmaTech Investments
Source ↗ - Undisclosed amountSeries BJan 2014
Avalon Ventures (lead), Torrey Pines Investment, WuXi AppTec
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avelas Biosciences do?
- Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
- Who are Avelas Biosciences's investors?
- Avelas Biosciences's investors include Torrey Pines Investment, Alexandria.